To invest in a concentrated portfolio of approximately 30-80 stocks of companies incorporated in emerging markets, and whose securities are listed or traded on a recognised market.
Name | % Net Assets |
---|---|
Petrobras | 5.2% |
Teva Pharmaceuticals | 4.7% |
China Mobile | 4.1% |
Vale On ADR | 4.0% |
Ind. & Comm. Bank of China | 3.9% |
Sasol | 3.7% |
Reliance Industries | 3.7% |
OAO Gazprom | 3.5% |
China Life Insurance | 3.0% |
Samsung Electronics | 2.9% |
Key | % Net Assets |
---|---|
Petrobras | 5.2% |
Teva Pharmaceuticals | 4.7% |
China Mobile | 4.1% |
Vale On ADR | 4.0% |
Other | 82% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 11/02/2009 |
---|---|
Fund Manager | n/a |
TER | 1.82 (15-Jan-2014) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research